Results 31 to 40 of about 7,409 (152)
Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis [PDF]
, 2021 PURPOSEHepatocellular carcinoma (HCC) usually occurs accompanied by portal hypertension. Transcatheter arterial chemoembolization (TACE) is recommended as an effective treatment in HCC.
Fei Gao +5 more
core +1 more source
Arquivos de Gastroenterologia, 2001 Diversas alternativas terapêuticas têm sido usadas, atualmente, na tentativa de reduzir a mortalidade de pacientes com hipertensão portal que desenvolvem varizes esofagianas.
Gerson CARREIRO +4 more
doaj +1 more source
Gut and Liver, 2018 Background/Aims Gastric varices (GVs) are a major cause of upper gastrointestinal bleeding in patients with liver cirrhosis. The current treatments of choice are balloon-occluded retrograde transvenous obliteration (BRTO) and the placement of a ...
Geunwu Gimm +8 more
doaj +1 more source
Endothelial Cells Lining Transjugular Intrahepatic Portasystemic Shunts Originate in Hepatic Sinusoids: Implications for Pseudointimal Hyperplasia [PDF]
Hepatology, 1999 The phenotype of the endothelial cells (ECs) in the pseudointima of transjugular intrahepatic portasystemic shunts (TIPS) and the mechanisms of pseudointima formation after TIPS were unknown. We hypothesized that TIPS were lined by hepatic sinusoidal ECs, which stimulated the migration of smooth muscle cells (SMCs) into the ...
A J, Sanyal, F, Mirshahi
openaire +2 more sources
Gastrointestinal Intervention, 2018 Background: To evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) creation for the management of portal hypertension in patients with hepatocellular carcinoma (HCC). Methods: A literature search of the MEDLINE/PubMed
He Zhao +5 more
doaj +1 more source
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt. [PDF]
, 2016 Cirrhotic patients with recurrent variceal bleeds who have failed prior medical and endoscopic therapies and are not transjugular intrahepatic portosystemic shunt candidates face a grim prognosis with limited options.
Borum, Marie L +2 more
core +2 more sources
Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: Characterization of cell phenotype and function [PDF]
Hepatology, 1998 The clinical utility of transjugular intrahepatic portasystemic shunts (TIPS) is frequently complicated by the ingrowth of tissue into the stent lumen, causing stent stenosis. These studies were undertaken to define the cellular and matrix components of the pseudointima, define the phenotype and function of the mesenchymal ...
A J, Sanyal +5 more
openaire +2 more sources
Journal of Digestive Diseases, Volume 25, Issue 3, Page 200-208, March 2024.The gut–liver axis is discussed to play an important role in hepatic cirrhosis. Decompensated liver cirrhosis is often associated with portal hypertension, which can lead to a variety of complications. The application of transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment option for the complications of portal hypertension.
Thomas Heller +9 more
wiley +1 more source
Duodenal variceal bleeding with large SPSS treated with transjugular intrahepatic portosystemic shunt and embolization: A case report [PDF]
, 2019 Background: Duodenal variceal bleeding is a rare cause of gastrointestinal bleeding. The most common site is the duodenal bulb. It is usually detected endoscopically but it can be very challenging to diagnose if it is located distal to the second part of
Ali, Saad Emhmed +3 more
core +1 more source
Portal Hypertension & CirrhosisHepatic encephalopathy (HE) is a frequent complication that occurs following transjugular intrahepatic portosystemic shunt (TIPS) procedures and has a considerable effect on patient prognosis.
Lixin Song, Xinyi Qiao, Yu Sun, Hui Yang
doaj +1 more source